0903 GMT - Allianz Health is a growth engine within the German insurer, Keefe, Bruyette & Woods says in a research note. The unit includes the non-life and life divisions for external reporting purposes but is a clearer third silo internally. It has historically delivered double-digit operating profit growth, which it seems management hopes to maintain, analyst William Hawkins writes. The division has the potential for structural growth, the analyst says. It has seen margin improvement in its core European markets and growth in mostly Asian developing economies, which the insurer has flagged as markets with high growth potential, he notes. Shares trade at 344.2 euros and have risen 16% since the start of the year. (elena.vardon@wsj.com)
(END) Dow Jones Newswires
June 30, 2025 05:03 ET (09:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。